2020’s virtual ASH conference hosted some fascinating and ground breaking findings on MPNs.
This information is all courtesy of MPN Hub.

• Does interferon alpha prolong survival and prevent progression in patients with PV?
  A longitudinal study of 470 PV patients showing superior myelofibrosis free and overall survival in patients treated with interferon – 5 min video summary.
• ASH 2020: Practice-changing abstracts for MPN
  Promising treatments for myelofibrosis refractory to ruxolitinib as well as two studies showing effectiveness of interferon as an MPN treatment – 4 min video summary.
• MPN driver mutations can be detected decades before the clinical diagnosis
  These findings also were also able to estimate clones growth rates, which could help predict disease presentation and prevent it.